In this section
Clinical trials
- Participate in a clinical trial
- For medical professionals
- Active clinical trials for pediatric cancers
- CAR-20/19-T cells in pediatric and young adult patients with relapsed/refractory B Cell Acute Lymphoblastic Leukemia (CAR-20/19-T) phase 1 clinical trial
- Unrelated and partially matched related donor peripheral stem cell transplantation for patients with hematologic malignancies clinical trial
- Early stage research
Active clinical trials
Cancer Clinical Trials - IIT-STEINECK-SARCAT-QOL
Protocol Summary
- Protocol No
- IIT-STEINECK-SARCAT-QOL
- Principal Investigator
- Angela Steineck
- Phase
- N/A
- Title
- SARCAT-QOL: Patient Reported Quality of Life After Treatment for Pediatric High-Risk Bone and Soft Tissue Sarcomas
- Associated Disease(s)
-
Ewing Sarcoma
Osteosarcoma
Other Solid Tumor
Rhabdomyosarcoma
- Description (Summary)
- The overarching objective of this study is to describe the QOL of pediatric patients in who have recently completed standard therapy for a high-risk bone or soft tissue sarcoma.
- Participating Institutions
- Childrens Hospital of Wisconsin
- ClinicalTrials.gov
Contact us
For more information about cancer and blood disorders clinical trials, email us or call
(414) 955-4727
Get a second opinion
It's important to know what your options are. We can provide expert opinions to verify or give more information about an initial diagnosis. Contact us today.
Why participate in clinical trials?
